3 studies found for:    TH-CR-404
Show Display Options
Rank Status Study
1 Active, not recruiting Study of the Safety and Efficacy of TH-302 in Combination With Gemcitabine Compared With Gemcitabine Alone in Previously Untreated Patients With Pancreatic Adenocarcinoma
Condition: Pancreatic Adenocarcinoma
Interventions: Drug: Gemzar (Gemcitabine);   Drug: TH-302
2 Active, not recruiting
Has Results
A Study of Paclitaxel With or Without Ramucirumab (IMC-1211B) in Metastatic Gastric Adenocarcinoma
Condition: Gastric Cancer
Interventions: Biological: Ramucirumab (IMC-1211B) DP;   Drug: Placebo;   Drug: Paclitaxel
3 Active, not recruiting Study to Evaluate the Efficacy and Safety of Tenofovir Disoproxil Fumarate (TDF) in Combination With Peginterferon α-2a vs Standard of Care Tenofovir Disoproxil Fumarate Monotherapy or Peginterferon α-2a Monotherapy for 48 Weeks in Chronic Hepatitis B(CHB).
Condition: Chronic Hepatitis B
Interventions: Drug: Tenofovir disoproxil fumarate 300 mg(TDF) and Peginterferon α-2a 180 µg(PEG);   Drug: Tenofovir Disoproxil Fumarate, Peginterferon α-2a;   Drug: Tenofovir Disoproxil Fumarate;   Drug: Peginterferon α-2a

Indicates status has not been verified in more than two years